AUD268.81
0.32% today
Australia, Apr 03, 07:10 am CET
ISIN
AU000000COH5
Symbol
COH
Sector

Cochlear Target price 2025 - Analyst rating & recommendation

Cochlear Classifications & Recommendation:

Buy
33%
Hold
56%
Sell
11%

Cochlear Price Target

Target Price AUD292.60
Price AUD268.81
Potential
Number of Estimates 16
16 Analysts have issued a price target Cochlear 2026 . The average Cochlear target price is AUD292.60. This is higher than the current stock price. The highest price target is
AUD331.34 23.26%
register free of charge
, the lowest is .
A rating was issued by 18 analysts: 6 Analysts recommend Cochlear to buy, 10 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Cochlear stock has an average upside potential 2026 of . Most analysts recommend the Cochlear stock at Hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Revenue Billion AUD 2.26 2.41
15.47% 6.79%
EBITDA Margin 26.85% 26.28%
6.46% 2.13%
Net Margin 15.72% 17.00%
3.09% 8.13%

16 Analysts have issued a sales forecast Cochlear 2025 . The average Cochlear sales estimate is

AUD2.4b
Unlock
. This is
4.18% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
AUD2.4b 5.34%
Unlock
, the lowest is
AUD2.4b 2.14%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 AUD2.3b 15.47%
2025
AUD2.4b 6.79%
Unlock
2026
AUD2.7b 10.17%
Unlock
2027
AUD2.9b 9.62%
Unlock
2028
AUD3.3b 11.72%
Unlock
2029
AUD3.6b 10.39%
Unlock

16 Analysts have issued an Cochlear EBITDA forecast 2025. The average Cochlear EBITDA estimate is

AUD634m
Unlock
. This is
6.21% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
AUD667m 11.76%
Unlock
, the lowest is
AUD603m 1.09%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 AUD606m 22.93%
2025
AUD634m 4.53%
Unlock
2026
AUD716m 13.02%
Unlock
2027
AUD799m 11.46%
Unlock
2028
AUD929m 16.35%
Unlock
2029
AUD1.0b 12.31%
Unlock

EBITDA Margin

2024 26.85% 6.46%
2025
26.28% 2.13%
Unlock
2026
26.97% 2.63%
Unlock
2027
27.42% 1.67%
Unlock
2028
28.55% 4.12%
Unlock
2029
29.05% 1.75%
Unlock

10 Cochlear Analysts have issued a net profit forecast 2025. The average Cochlear net profit estimate is

AUD410m
Unlock
. This is
10.99% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
AUD413m 11.73%
Unlock
, the lowest is
AUD405m 9.77%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 AUD355m 19.04%
2025
AUD410m 15.47%
Unlock
2026
AUD431m 5.08%
Unlock
2027
AUD508m 17.81%
Unlock
2028
AUD626m 23.36%
Unlock
2029
AUD714m 14.08%
Unlock

Net Margin

2024 15.72% 3.09%
2025
17.00% 8.13%
Unlock
2026
16.21% 4.65%
Unlock
2027
17.43% 7.53%
Unlock
2028
19.24% 10.38%
Unlock
2029
19.88% 3.33%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Earnings Per Share AUD 5.44 6.28
19.04% 15.44%
P/E 42.66
EV/Sales 7.19

10 Analysts have issued a Cochlear forecast for earnings per share. The average Cochlear EPS is

AUD6.28
Unlock
. This is
10.95% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
AUD6.32 11.66%
Unlock
, the lowest is
AUD6.21 9.72%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 AUD5.44 19.04%
2025
AUD6.28 15.44%
Unlock
2026
AUD6.60 5.10%
Unlock
2027
AUD7.78 17.88%
Unlock
2028
AUD9.59 23.26%
Unlock
2029
AUD10.94 14.08%
Unlock

P/E ratio

Current 47.36 25.08%
2025
42.66 9.92%
Unlock
2026
40.59 4.85%
Unlock
2027
34.46 15.10%
Unlock
2028
27.93 18.95%
Unlock
2029
24.48 12.35%
Unlock

Based on analysts' sales estimates for 2025, the Cochlear stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 7.49 25.32%
2025
7.19 3.98%
Unlock
2026
6.53 9.23%
Unlock
2027
5.95 8.78%
Unlock
2028
5.33 10.49%
Unlock
2029
4.83 9.41%
Unlock

P/S ratio

Current 7.55 25.65%
2025
7.25 4.01%
Unlock
2026
6.58 9.23%
Unlock
2027
6.00 8.78%
Unlock
2028
5.37 10.49%
Unlock
2029
4.87 9.41%
Unlock

Current Cochlear Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
WILSONS
Locked
Locked
Locked Jan 06 2025
MACQUARIE RESEARCH
Locked
Locked
Locked Oct 28 2024
Analyst Rating Date
Locked
WILSONS:
Locked
Locked
Jan 06 2025
Locked
MACQUARIE RESEARCH:
Locked
Locked
Oct 28 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today